Akademska digitalna zbirka SLovenije - logo
E-resources
Full text
Peer reviewed
  • Lixisenatide rescues spatia...
    Cai, H.-Y; Hölscher, C; Yue, X.-H; Zhang, S.-X; Wang, X.-H; Qiao, F; Yang, W; Qi, J.-S

    Neuroscience, 09/2014, Volume: 277
    Journal Article

    Highlights • Lixisenatide, a novel drug treatment for diabetes, shows neuroprotective effects. • Lixisenatide prevented the Aβ25–35 induced impairment in spatial learning. • The drug prevented the Aβ25–35 induced block of LTP in the hippocampus. • The drug inhibited the Aβ25–35 induced activation of glycogen synthase kinase 3β.